Loading insider details...
Beta
Latest Form 4 (Jun 5, 2026): Grant/Award of 19,676 BEAM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 5, 2026 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 19,676 | n/a |
| May 11, 2026 | Kezar Life Sciences, Inc. (KZR) | Disposition to Issuer | 3,742 | n/a |
| Jun 23, 2025 | Kezar Life Sciences, Inc. (KZR) | Grant/Award | 5,000 | n/a |
| Jun 6, 2025 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 33,662 | n/a |
| Jun 21, 2024 | Kezar Life Sciences, Inc. (KZR) | Grant/Award | 50,000 | n/a |
| Jun 7, 2024 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 23,114 | n/a |
| Jul 26, 2023 | Kezar Life Sciences, Inc. (KZR) | Disposition to Issuer | 8,896 | n/a |
| Jun 16, 2023 | Kezar Life Sciences, Inc. (KZR) | Grant/Award | 35,000 | n/a |
| Jun 8, 2023 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 16,532 | n/a |
| Sep 2, 2022 | Beam Therapeutics Inc. (BEAM) | Grant/Award | 10,391 | n/a |